Hematology and Hemotherapy Center - University of Campinas/Hemocentro - Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil.
Hematology and Hemotherapy Center - University of Campinas/Hemocentro - Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil; Department of Biological Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.
Leuk Res. 2014 Feb;38(2):251-7. doi: 10.1016/j.leukres.2013.11.013. Epub 2013 Dec 1.
Stathmin 1 is an important cytoplasmic microtubule-destabilizing protein that plays critical roles in proliferation and accurate chromosome segregation through regulation of microtubule dynamics. High levels of Stathmin 1 expression have been reported in leukemia and solid tumors. However, Stathmin 1 has not been studied in myelodysplastic syndrome cells. We, herein, report that significantly higher Stathmin 1 levels were observed in proliferating hematopoietic cells, in high-risk MDS and acute leukemia cells. In addition, Stathmin 1 silencing in U937 and Namalwa leukemia cells reduced cell proliferation and clonogenicity. Our data suggest that Stathmin 1 expression may be related to the highly proliferative phenotype of hematopoietic cells and add new insights into the participation of Stathmin 1 in hematological malignancies.
Stathmin 1 是一种重要的细胞质微管解聚蛋白,通过调节微管动力学,在增殖和准确的染色体分离中发挥关键作用。已有报道称,Stathmin 1 在白血病和实体瘤中高表达。然而,在骨髓增生异常综合征细胞中尚未对 Stathmin 1 进行研究。我们在此报告,在增殖的造血细胞、高危 MDS 和急性白血病细胞中观察到 Stathmin 1 水平显著升高。此外,U937 和 Namalwa 白血病细胞中的 Stathmin 1 沉默降低了细胞增殖和集落形成能力。我们的数据表明,Stathmin 1 的表达可能与造血细胞的高增殖表型有关,并为 Stathmin 1 参与血液恶性肿瘤提供了新的见解。